Lymphomatoid papulosis during upadaci-tinib treatment for rheumatoid arthritis.
作者信息
Iinuma Shin, Hayashi Kei, Noguchi Atsushi, Ishida-Yamamoto Akemi
出版信息
Eur J Dermatol. 2022 Jan 1;32(1):142-143. doi: 10.1684/ejd.2022.4238.
Abstract
摘要
相似文献
1
Lymphomatoid papulosis during upadaci-tinib treatment for rheumatoid arthritis.
Eur J Dermatol. 2022 Jan 1;32(1):142-143. doi: 10.1684/ejd.2022.4238.
2
Lymphomatoid papulosis in a patient treated with adalimumab for juvenile rheumatoid arthritis.
Dermatology. 2012;225(3):259-63. doi: 10.1159/000345104. Epub 2012 Dec 13.
3
Lymphomatoid papulosis: A cutaneous lymphoproliferative disorder in a patient on fingolimod for multiple sclerosis.
Mult Scler. 2016 Jan;22(1):122-4. doi: 10.1177/1352458515597568. Epub 2015 Jul 28.
4
Lymphomatoid papulosis and fingolimod-A new connection?
Mult Scler. 2016 Oct;22(12):1629-1630. doi: 10.1177/1352458516639759. Epub 2016 Mar 18.
5
Lymphomatoid papulosis and FK 506.
Int J Dermatol. 1997 Mar;36(3):202-5. doi: 10.1111/j.1365-4362.1997.tb04181.x.
6
[Minocycline-induced lymphomatoid papulosis].
Rev Med Interne. 2004 May;25(5):401-4. doi: 10.1016/j.revmed.2004.02.010.
7
Verapamil and lymphomatoid papulosis in chronic cluster headache.
J Neurol. 2004 Apr;251(4):473-5. doi: 10.1007/s00415-004-0290-x.
8
Tattoos and coincidental skin conditions: the example of lymphomatoid papulosis.
Br J Dermatol. 2014 Dec;171(6):1561. doi: 10.1111/bjd.13120. Epub 2014 Dec 11.
9
Lymphomatoid papulosis while on efalizumab.
J Am Acad Dermatol. 2009 Sep;61(3):540-1. doi: 10.1016/j.jaad.2008.12.010.
10
Lymphomatoid papulosis type D in a fingolimod-treated multiple sclerosis patient.
Mult Scler. 2016 Oct;22(12):1630-1631. doi: 10.1177/1352458516642032. Epub 2016 Apr 6.
引用本文的文献
1
Drug- and Vaccine-Induced Cutaneous T-Cell Lymphoma: A Systematic Review of the Literature.
J Skin Cancer. 2025 Feb 27;2025:3103865. doi: 10.1155/jskc/3103865. eCollection 2025.
2
Therapeutic Targeting of the Janus Kinase/Signal Transducer and Activator of Transcription Pathway in Cutaneous T-Cell Lymphoma.
Cancers (Basel). 2025 Feb 7;17(4):568. doi: 10.3390/cancers17040568.
3
JAK Inhibitors in Cutaneous T-Cell Lymphoma: Friend or Foe? A Systematic Review of the Published Literature.
Cancers (Basel). 2024 Feb 21;16(5):861. doi: 10.3390/cancers16050861.
本文引用的文献
1
Safety profile of upadacitinib in rheumatoid arthritis: integrated analysis from the SELECT phase III clinical programme.
Ann Rheum Dis. 2021 Mar;80(3):304-311. doi: 10.1136/annrheumdis-2020-218510. Epub 2020 Oct 28.
2
Lymphomatoid Papulosis Type B in a Patient with Crohn's Disease Treated with TNF-Alpha Inhibitors Infliximab and Adalimumab.
Acta Dermatovenerol Croat. 2019 Sep;27(3):202-204.
3
Lymphomatoid papulosis in a patient treated with adalimumab for juvenile rheumatoid arthritis.
Dermatology. 2012;225(3):259-63. doi: 10.1159/000345104. Epub 2012 Dec 13.
4
EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma.
Blood. 2011 Oct 13;118(15):4024-35. doi: 10.1182/blood-2011-05-351346. Epub 2011 Aug 12.
5
Lymphomatoid papulosis in a patient with atopic eczema on long-term ciclosporin therapy.
Br J Dermatol. 2005 Jun;152(6):1346-8. doi: 10.1111/j.1365-2133.2005.06548.x.
Zotero 插件